AWM
OLMA icon

Activest Wealth Management’s Olema Pharmaceuticals OLMA Stock Holding History

Activest Wealth Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$13 – 1457
2026
Q1 		$13 Hold
1
– – ﹤0.01% 1215
2025
Q4 		$13 Buy
+1
New +$18 ﹤0.01% 1108

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Activest Wealth Management's OLMA Position: Q2 2026 in Review

Activest Wealth Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 1 share — an estimated $13 sold.

Activest Wealth Management first reported a position in OLMA in Q4 2025 and held it in 2 quarters. The position peaked at $13 in Q1 2026. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Activest Wealth Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Activest Wealth Management sold 1 Olema Pharmaceuticals share in Q2 2026, an estimated $13.
  • Activest Wealth Management first reported a position in Olema Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Activest Wealth Management's Olema Pharmaceuticals position peaked at $13 in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.